Trademark: VICORE 2083346
Word
VICORE
ID
2083346
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
23 January 2020
Registration Date
23 January 2020
Renewal Date
23 January 2030
Owner(s)
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 5:
Pharmaceuticals and medical preparations for human use; pharmaceutical preparations within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for pulmonary fibrosis namely ipf; pharmaceutical preparations for diffuse systemic sclerosis (lung manifestations); pharmaceutical preparations for pulmonary sarcoidosis.
Pharmaceuticals and medical preparations for human use; pharmaceutical preparations within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; pharmaceutical preparations for pulmonary fibrosis namely ipf; pharmaceutical preparations for diffuse systemic sclerosis (lung manifestations); pharmaceutical preparations for pulmonary sarcoidosis.
Class 42:
Medical and pharmacological research services; medical and pharmacological research services within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; medical and pharmacological research services within the fields of pulmonary fibrosis namely ipf, pulmonary sarcoidosis and diffuse systemic sclerosis (lung manifestations); pharmaceutical research and development; scientific research and development; medical research laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical development services; pharmaceutical delivery system development services; preparation and/or formulation of pharmaceuticals; medical product testing services; clinical research and professional expertise relating thereto.
Medical and pharmacological research services; medical and pharmacological research services within the fields of pulmonary diseases, cardiovascular diseases, autoimmune and inflammatory diseases, fibrotic diseases and kidney diseases; medical and pharmacological research services within the fields of pulmonary fibrosis namely ipf, pulmonary sarcoidosis and diffuse systemic sclerosis (lung manifestations); pharmaceutical research and development; scientific research and development; medical research laboratory services; medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical development services; pharmaceutical delivery system development services; preparation and/or formulation of pharmaceuticals; medical product testing services; clinical research and professional expertise relating thereto.